Subscribe Now/Learn More
PsychiatryOnline subscription options offer access to the
DSM-5 library, books,
journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists
and mental health professionals with key resources for diagnosis, treatment, research,
and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org
or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
Frank et al. 2005
Bipolar I disorder
Intensive clinical management
Participants assigned to IPSRT in the acute treatment
phase had a longer period without a new affective episode, higher regularity
of social rhythms, and reduced likelihood of recurrence during maintenance
de Mello et al. 2001
Moclobemide plus IPT
Moclobemide (300 mg/day)
Both moclobemide-plus-IPT and moclobemide-alone groups
showed statistically significant improvement in all measures across
time. Moclobemide-plus-IPT group had higher retention and statistically
better scores than group receiving moclobemide alone on all outcome
variables at weeks 24 and 48.
Browne et al. 2002
Dysthymic disorder with or without past or current MDD
Sertraline alone (50–200 mg)
IPT plus sertraline
Sertraline group and sertraline plus IPT group had
higher response rates after 6 months and greater reduction in depressive
symptoms at 2 years compared with IPT group.
Markowitz et al. 2005
Dysthymic disorder without MDD in prior 6 months
Sertraline plus IPT
Sertraline group had superior response and remission
rates compared with groups receiving psychotherapy alone. Groups
receiving sertraline or sertraline plus IPT had higher response
rates compared with groups receiving psychotherapy alone.
Note. BSP = brief
supportive psychotherapy; IPSRT = interpersonal and social
rhythm therapy; IPT = interpersonal therapy; MDD = major